# OnCo record dualitybio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dualitybio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dualitybio" ;
  schema:name "Duality Biotherapeutics"@en ;
  schema:alternateName "DualityBio Inc."@en ;
  schema:description "Chinese ADC platform company behind BioNTech's trastuzumab pamirtecan (BNT323/DB-1303) and AI-nominated targets."@en ;
  schema:url <https://onco.cc/companies/dualitybio/>, <https://www.dualitybiologics.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://web.archive.org/web/20211202003714/http://dualitybiotherapeutics.com/> ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/b7h3/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-pamirtecan/> ;
  onco:trials <https://onco.cc/trials/nct05914116/>, <https://onco.cc/trials/nct07263594/>, <https://onco.cc/trials/nct06554795/>, <https://onco.cc/trials/nct05785741/>, <https://onco.cc/trials/nct06827236/>, <https://onco.cc/trials/nct05438329/>, <https://onco.cc/trials/nct05150691/>, <https://onco.cc/trials/nct06892548/>, <https://onco.cc/trials/nct06953089/> .